Workflow
Tejon Ranch Co. Emphasizes Commitment to Execution, Oversight and Transparency
GlobeNewswire· 2025-05-01 13:15
Bulldog’s Apparent Lack of Understanding of Tejon’s Business Risks Significant Value Destruction at Tejon Urges Shareholders to Vote “FOR” ALL of Tejon Ranch’s 10 Highly Qualified Director Nominees on the WHITE Proxy Card TEJON RANCH, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co. (NYSE:TRC), (“Tejon” or the “Company”), a diversified real estate development and agribusiness company, today announced that it has mailed a letter to shareholders in connection with its upcoming Annual Meeting of Shareh ...
Greenlight Re Announces Appointment of Martin Vezina as Head of Underwriting Analytics
GlobeNewswire· 2025-05-01 13:00
GRAND CAYMAN, Cayman Islands, May 01, 2025 (GLOBE NEWSWIRE) -- Greenlight Reinsurance, Ltd. (“Greenlight Re” or the “Company”), a subsidiary of Greenlight Capital Re, Ltd. (NASDAQ: GLRE), today announced the appointment of Martin Vezina as Head of Underwriting Analytics with immediate effect. In this capacity, Vezina will play a pivotal role in overseeing Greenlight Re’s underwriting analytics and pricing function and will be based out of the Company’s headquarters in Grand Cayman. “I am excited to join Gre ...
Antelope Enterprise Announces Second Half and Full Year 2024 Financial Results
GlobeNewswire· 2025-05-01 13:00
AEHL Second Half Revenue Increased by 100% Year-over-YearNEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), which operates KylinCloud, a livestreaming ecommerce business in China, today announced its financial results for the second half and fiscal year ended December 31, 2024. Fiscal Year 2024 Summary Revenue was $98.7 million, an increase of 37% as compared to $72.1 million for fiscal year 2023.Gro ...
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure
GlobeNewswire· 2025-05-01 13:00
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the first patient enrolled in the Phase III randomized procedure placebo-controlled double-blind CardiAMP HF II clinical trial of the Company’s lead autologous cell therapy program for the treatment of heart failure at BayCare Morton Plant Hospital in Clearwater, Florida. “We are excited to le ...
LEEF Brands Reports First Quarter 2025 and Full-Year 2024 Financial Results
GlobeNewswire· 2025-05-01 13:00
VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) -- LEEF Brands Inc. (CSE: LEEF) (OTCQB: LEEEF) (the “Company” or “LEEF Brands”), one of California’s largest and most sophisticated cannabis companies, today announced its financial results for the first quarter ended March 31, 2025, and full-year results for the year ended December 31, 2024. First Quarter 2025 Financial Highlights vs. First Quarter 2024: Revenue of $9.4 million, up 19% from $7.9 million, reflecting strengthening market demand and i ...
Data Storage Corporation Schedules First Quarter 2025 Business Update Conference Call
GlobeNewswire· 2025-05-01 13:00
MELVILLE, N.Y., May 01, 2025 (GLOBE NEWSWIRE) -- Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a leading provider of multi-cloud hosting, managed cloud services, disaster recovery, cybersecurity, and IT automation, integrating seamlessly with AWS, Microsoft Azure, and Google Cloud, today announced plans to host a conference call at 11:00 a.m. Eastern Time on Thursday, May 15, 2025, to discuss the Company's progress and the financial results for the first quarter of 2025, which ended Mar ...
Mont Sorcier Iron Vanadium Update
GlobeNewswire· 2025-05-01 13:00
ROUYN-NORANDA, Québec, May 01, 2025 (GLOBE NEWSWIRE) -- Chibougamau Independent Mines Inc. (CBG-TSXV in Canada, CLL1-Frankfurt, Stuttgart and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC in the US) and GLOBEX MINING ENTERPRISES INC. (GMX–TSX, G1MN–Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, L&S Exchange, TTMzero, Düsseldorf, Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) are pleased to provide an update as reported by Cerrado Gold Inc. (TSX.V: CERT ...
CN to Report First-Quarter 2025 Financial and Operating Results Today
GlobeNewswire· 2025-05-01 13:00
MONTREAL, May 01, 2025 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) will issue its first-quarter 2025 financial and operating results after the market close. CN's senior officers will review the results and the railway's outlook in a conference call starting at 4:30 p.m. Eastern Time today. Tracy Robinson, CN President and Chief Executive Officer, will lead the call. Parties wishing to participate via telephone may dial 1-800-715-9871 (Canada/U.S.), or 1-647-932-3411 (International), using 3839820 as the p ...
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
GlobeNewswire· 2025-05-01 13:00
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic obstructive pulmonary disease (COPD) and asthma COPD data from the landmark Phase 3 trials will highlight Dupixent impact on lung function and health-related quality of life across broad populations of patients with type 2 inflammation Asthma abstracts include late-breaking data on mucus burden and the first presentation of efficacy results from a Phase 2 trial de ...
Resmed Acquires VirtuOx
GlobeNewswire· 2025-05-01 13:00
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providersSAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The acquisition reflects Resmed’s commitment to ...